close
close

Analyst Ratings Chart: 6 Ratings for Encompass Health – Encompass Health (NYSE:EHC)

Analyst Ratings Chart: 6 Ratings for Encompass Health – Encompass Health (NYSE:EHC)

Six analysts have issued ratings on Encompass Health in the last three months EHKIt offers a variety of perspectives, from bull to bear.

The table below summarizes recent ratings, showing changing sentiment over the past 30 days and comparing them to previous months.

Bull A little bit of bull Indifferent A Little Bear Bear
Total Points 2 4 0 0 0
Last 30D 0 one 0 0 0
1M Ago 0 0 0 0 0
2M Ago 0 2 0 0 0
3M First 2 one 0 0 0

The 12-month price targets evaluated by analysts reveal further insights, which include an average target of $97.83, a high estimate of $108.00, and a low estimate of $94.00. Witnessing a positive change, the current average is 7.27% higher than the previous average price target of $91.20.

Interpreting Analyst Ratings: A Closer Look

A comprehensive look at how financial experts perceive Encompass Health is derived from recent analyst actions. Below is a detailed summary of key analysts, their recent evaluations, and adjustments to their ratings and price targets.

Analyst Analyst Firm Action Taken Evaluation Current Price Target Previous Price Target
White Mayonnaise Leerink Partners Announcements Superior performance $100.00
Scott Fidel Stephens and Company Protects Fat $94.00 $94.00
Ben Hendrix RBC Capital Increases Superior performance $95.00 $83.00
John Ransom Raymond James Increases Strong Buying $95.00 $85.00
Andrew Mock Barclays Increases Fat $108.00 $101.00
Anne Hynes Mizuho Increases To buy $95.00 $93.00

Basic knowledge:

  • Action Taken: Analysts frequently update their recommendations based on changing market conditions and company performance. Their stance of ‘Hold,’ ‘Raise,’ or ‘Reduce’ reflects their reaction to recent developments regarding Encompass Health. This information provides a snapshot of how analysts perceive the current health of the company.
  • Evaluation: Analysts providing ratings assign qualitative scores from ‘Outperform’ to ‘Underperform.’ These ratings convey expectations about Encompass Health’s relative performance compared to the broader market.
  • Price Targets: Analysts provide estimates of the future value of Encompass Health stock, studying the dynamics of price targets. This study reveals changes in analysts’ expectations over time.

Evaluating these analyst ratings along with critical financial indicators can provide a comprehensive overview of Encompass Health’s market position. Stay informed and make well-considered decisions with the help of our Ratings Table.

Stay up to date on Encompass Health analyst ratings.

About Encompass Health

Encompass Health Corp. provides post-acute healthcare services through a network of inpatient rehabilitation hospitals in the United States. Inpatient rehabilitation accounts for the majority of the firm’s revenue and provides specialized rehabilitation treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and in Texas.

Unraveling Encompass Health’s Financial Story

Market capitalization: The company’s market value, which exceeds industry standards, demonstrates its dominance in terms of size and indicates a strong market position.

Income increase: Encompass Health’s remarkable performance in 3 months speaks for itself. The company has achieved an impressive revenue growth rate as of March 31, 2024. 13.41%This represents a significant increase in the company’s top-line earnings. Compared to its peers, the company has achieved a higher than average growth rate among its competitors in the Healthcare sector.

Net Profit Margin: Encompass Health’s net profit margin exceeds industry standards 8.55%This is an indication of effective cost management and strong financial health.

Return on Equity (ROE): Encompass Health’s ROE is below industry standards, indicating difficulties in using equity capital efficiently. 6.64%, The company may face difficulties in generating satisfactory returns for shareholders.

Return on Assets (ROA): The company’s ROA is a standout performer, exceeding industry averages. With an impressive ROA 1.82%, The company demonstrates efficient use of assets.

Debt management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, and 1.68.

Understanding the Importance of Analyst Ratings

In the banking and financial systems field, analysts specialize in reporting on specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements and communicating with insiders to issue “analyst ratings” for stocks. Analysts typically evaluate and rate each stock on a quarterly basis.

Beyond their standard ratings, some analysts provide additional guidance to investors by making estimates for metrics such as growth estimates, earnings, and revenue. Users of analyst ratings should note that this particular advice is informed by human perspectives and is subject to change.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.